CONMED Corporation (CNMD): Price and Financial Metrics
CNMD Price/Volume Stats
Current price | $101.15 | 52-week high | $138.47 |
Prev. close | $101.42 | 52-week low | $71.09 |
Day low | $99.95 | Volume | 364,800 |
Day high | $101.97 | Avg. volume | 376,752 |
50-day MA | $113.45 | Dividend yield | 0.79% |
200-day MA | $109.44 | Market Cap | 3.11B |
CNMD Stock Price Chart Interactive Chart >
CNMD POWR Grades
- Value is the dimension where CNMD ranks best; there it ranks ahead of 60.62% of US stocks.
- CNMD's strongest trending metric is Stability; it's been moving up over the last 179 days.
- CNMD ranks lowest in Sentiment; there it ranks in the 9th percentile.
CNMD Stock Summary
- CNMD's went public 33.51 years ago, making it older than 85.21% of listed US stocks we're tracking.
- Price to trailing twelve month operating cash flow for CNMD is currently 89.41, higher than 97.01% of US stocks with positive operating cash flow.
- In terms of twelve month growth in earnings before interest and taxes, CONMED CORP is reporting a growth rate of -2,840.15%; that's higher than merely 0.48% of US stocks.
- If you're looking for stocks that are quantitatively similar to CONMED CORP, a group of peers worth examining would be WFRD, DGLY, MARK, DHX, and CDRE.
- Visit CNMD's SEC page to see the company's official filings. To visit the company's web site, go to www.conmed.com.
CNMD Valuation Summary
- In comparison to the median Healthcare stock, CNMD's price/earnings ratio is 37.98% higher, now standing at 37.6.
- CNMD's price/sales ratio has moved up 1.6 over the prior 243 months.
Below are key valuation metrics over time for CNMD.
Stock | Date | P/S | P/B | P/E | EV/EBIT |
---|---|---|---|---|---|
CNMD | 2023-09-18 | 2.9 | 4.3 | 37.6 | 68.5 |
CNMD | 2023-09-15 | 2.9 | 4.2 | 37.5 | 68.3 |
CNMD | 2023-09-14 | 2.9 | 4.2 | 37.5 | 68.4 |
CNMD | 2023-09-13 | 2.9 | 4.2 | 37.4 | 68.2 |
CNMD | 2023-09-12 | 2.9 | 4.2 | 37.5 | 68.4 |
CNMD | 2023-09-11 | 2.9 | 4.3 | 37.9 | 69.0 |
CNMD Growth Metrics
- Its 5 year cash and equivalents growth rate is now at -29.86%.
- Its 4 year cash and equivalents growth rate is now at -29.86%.
- Its 2 year revenue growth rate is now at 7.32%.

The table below shows CNMD's growth in key financial areas (numbers in millions of US dollars).
Date | Revenue | Operating Cash Flow | Net Income to Common Stock |
---|---|---|---|
2022-09-30 | 1,068.575 | 78.748 | -82.722 |
2022-06-30 | 1,042.314 | 74.217 | -113.924 |
2022-03-31 | 1,020.285 | 89.754 | 67.657 |
2021-12-31 | 1,010.635 | 111.77 | 62.542 |
2021-09-30 | 989.493 | 98.13 | 62.238 |
2021-06-30 | 978.501 | 111.894 | 54.14 |
CNMD's Quality Factors
The “Quality” component of the POWR Ratings focuses on 31 different factors of a companies fundamentals and operational strength. Here are some key insights as we drill into the specifics of these quality attributes.- CNMD has a Quality Grade of C, ranking ahead of 54.31% of graded US stocks.
- CNMD's asset turnover comes in at 0.564 -- ranking 77th of 186 Medical Equipment stocks.
- OSUR, MMSI, and BSX are the stocks whose asset turnover ratios are most correlated with CNMD.
The table below shows CNMD's key quality metrics over time.
Period | Asset Turnover | Gross Margin | ROIC |
---|---|---|---|
2021-09-30 | 0.564 | 0.554 | 0.083 |
2021-06-30 | 0.559 | 0.551 | 0.086 |
2021-03-31 | 0.506 | 0.533 | 0.045 |
2020-12-31 | 0.495 | 0.534 | 0.038 |
2020-09-30 | 0.500 | 0.534 | 0.041 |
2020-06-30 | 0.497 | 0.532 | 0.033 |
CONMED Corporation (CNMD) Company Bio
CONMED Corporation is a medical technology company that provides surgical devices and equipment for minimally invasive procedures. The Company's products are used by surgeons and physicians in a variety of specialties, including orthopedics, general surgery, gynecology, neurosurgery, and gastroenterology. The company was founded in 1970 and is based in Utica, New York.
Latest CNMD News From Around the Web
Below are the latest news stories about CONMED CORP that investors may wish to consider to help them evaluate CNMD as an investment opportunity.
Insider Sell: President AS and AET Peters Stanley W III Sells 2000 Shares of Conmed CorpOn September 13, 2023, Peters Stanley W III, President AS and AET of Conmed Corp (NYSE:CNMD), sold 2,000 shares of the company. |
CONMED Corporation to Participate in a Virtual Fireside Chat at the CL King Best Ideas ConferenceLARGO, Fla., September 05, 2023--CONMED Corporation (NYSE: CNMD) today announced that Todd W. Garner, Executive Vice President and Chief Financial Officer, will participate in a virtual fireside chat at the CL King 21st Annual Best Ideas Conference at 10:15 a.m. ET on Monday, September 18, 2023. |
Is a Beat Likely for Cooper Companies (COO) in Q3 Earnings?Cooper Companies' (COO) fiscal third-quarter results are likely to reflect segmental strength. |
Is a Beat Likely for Patterson Companies (PDCO) in Q1 Earnings?Patterson Companies' (PDCO) fiscal first-quarter results are likely to reflect an improvement at both Dental and Animal Health segments. |
CONMED Corporation to Participate in a Fireside Chat at the Wells Fargo Healthcare ConferenceLARGO, Fla., August 24, 2023--CONMED Corporation (NYSE: CNMD) today announced that Todd W. Garner, Executive Vice President and Chief Financial Officer, will participate in a fireside chat at the Wells Fargo Healthcare Conference at 2:15 p.m. ET on Thursday, September 7, 2023. |
CNMD Price Returns
1-mo | -6.13% |
3-mo | -22.92% |
6-mo | 3.12% |
1-year | 24.16% |
3-year | 41.01% |
5-year | 32.94% |
YTD | 14.75% |
2022 | -36.98% |
2021 | 27.35% |
2020 | 1.16% |
2019 | 75.71% |
2018 | 27.39% |
CNMD Dividends
Ex-Dividend Date | Type | Payout Amount | Change | ||||||
---|---|---|---|---|---|---|---|---|---|
Loading, please wait... |
Continue Researching CNMD
Want to do more research on Conmed Corp's stock and its price? Try the links below:Conmed Corp (CNMD) Stock Price | Nasdaq
Conmed Corp (CNMD) Stock Quote, History and News - Yahoo Finance
Conmed Corp (CNMD) Stock Price and Basic Information | MarketWatch
Loading social stream, please wait...